Insta
23 Die In Norway After Receiving First Dose Of Pfizer's COVID-19 Vaccine, Say Norwegian Medicines Agency Officials
Pfizer logo (Pic Via Wikipedia)
In a major development, as many as 23 people have died in Norway after receiving the first dose of Pfizer’s COVID-19 vaccine, according to the Norwegian health officials , reports New York Post.
As per Norwegian Medicines Agency’s chief physician Sigurd Hortemo, common reactions to the vaccine like fever and nausea may have resulted in a fatal outcome in some “frail patients”. Of the 23 who have lost lives, 13 were nursing home patients and at least 80-years-old.
However, the Agency’s medical director Steinar Madsen has stated that the agency is not alarmed by this. He said, “It is quite clear that these vaccines have very little risk, with a small exception for the frailest patients.”
Madsen also added, “Doctors must now carefully consider who should be vaccinated. Those who are very frail and at the very end of life can be vaccinated after an individual assessment.”
The development comes at a time when more than 30,000 people in Norway have already received the first dosage of COVID-19 vaccines developed by Pfizer or Moderna Inc.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
